本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

和黄医药

17.74
-0.0450-0.25%
成交量:4,597.00
成交额:8.16万
市值:30.93亿
市盈率:88.68
高:17.79
开:17.79
低:17.62
收:17.78
数据加载中...
2020/01/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/31

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/20

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/29

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/25

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/17

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/03

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/30

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/09/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/30

[补充]招股说明书

Filing under Securities Act Rules 163/433 of free writing prospectuses
2019/09/25

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]